Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-05-31 5:31 pm Sale | 2022-05-26 | 13D | KALA PHARMACEUTICALS INC KALA | RA CAPITAL MANAGEMENT L.P. | 4,956 8.530% | -1,480 (-23.00%) | Filing History |
| 2022-05-25 5:12 pm Sale | 2022-05-23 | 13D | KALA PHARMACEUTICALS INC KALA | RA CAPITAL MANAGEMENT L.P. | 6,436 11.080% | -2,296 (-26.29%) | Filing History |
| 2022-05-25 4:29 pm Purchase | 2022-05-15 | 13G | CELCUITY INC CELC | RA CAPITAL MANAGEMENT L.P. | 1,486,471 9.900% | 1,486,471 (New Position) | Filing History |
| 2022-05-20 4:30 pm Purchase | 2022-05-10 | 13D | PEPGEN INC PEPG | RA CAPITAL MANAGEMENT L.P. | 8,131,952 36.300% | 8,131,952 (New Position) | Filing History |
| 2022-05-16 4:33 pm Sale | 2022-05-16 | 13G | ZOGENIX INC ZGNX | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -3,333,700 (Position Closed) | Filing History |
| 2022-05-16 4:32 pm Sale | 2022-05-16 | 13G | PHATHOM PHARMACEUTICALS INC CO PHAT | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -3,115,008 (Position Closed) | Filing History |
| 2022-05-16 4:31 pm Sale | 2022-05-16 | 13G | BOLT BIOTHERAPEUTICS, INC BOLT | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -118,916 (Position Closed) | Filing History |
| 2022-05-16 4:30 pm Sale | 2022-05-16 | 13G | OLEMA PHARMACEUTICALS INC OLMA | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -2,150,404 (Position Closed) | Filing History |
| 2022-05-02 4:30 pm Purchase | 2022-04-28 | 13D | NKARTA INC NKTX | RA CAPITAL MANAGEMENT L.P. | 7,832,340 16.200% | 2,227,211 (+39.74%) | Filing History |
| 2022-04-28 4:58 pm Purchase | 2022-04-18 | 13G | NANOSTRING TECHNOLOGIES INC CO NSTGQ | RA CAPITAL MANAGEMENT L.P. | 3,517,694 7.700% | 3,517,694 (New Position) | Filing History |
| 2022-04-25 4:30 pm Purchase | 2022-04-13 | 13G | ACLARIS THERAPEUTICS INC ACRS | RA CAPITAL MANAGEMENT L.P. | 4,398,453 7.100% | 4,398,453 (New Position) | Filing History |
| 2022-04-21 4:30 pm Purchase | 2022-04-11 | 13G | VERU INC VERU | RA CAPITAL MANAGEMENT L.P. | 790,000 9.870% | 790,000 (New Position) | Filing History |
| 2022-04-08 4:31 pm Purchase | 2022-03-29 | 13G | AN2 THERAPEUTICS INC ANTX | RA CAPITAL MANAGEMENT L.P. | 3,666,663 19.600% | 3,666,663 (New Position) | Filing History |
| 2022-04-01 4:30 pm Sale | 2022-03-30 | 13D | KALA PHARMACEUTICALS INC KALA | RA CAPITAL MANAGEMENT L.P. | 8,732 15.030% | -37 (-0.42%) | Filing History |
| 2022-03-24 4:30 pm Purchase | 2022-03-14 | 13G | STANDARD BIOTOOLS INC. LAB | RA CAPITAL MANAGEMENT L.P. | 4,651,177 6.000% | 4,651,177 (New Position) | Filing History |
| 2022-03-14 5:04 pm Purchase | 2022-03-10 | 13D | CYTEK BIOSCIENCES INC CTKB | RA CAPITAL MANAGEMENT L.P. | 13,139,327 9.800% | 2,057,164 (+18.56%) | Filing History |
| 2022-02-28 5:29 pm Purchase | 2022-02-28 | 13D | CYTEK BIOSCIENCES INC CTKB | RA CAPITAL MANAGEMENT L.P. | 11,082,163 8.300% | 1,475,135 (+15.35%) | Filing History |
| 2022-02-24 4:30 pm Purchase | 2022-02-14 | 13G | VERA THERAPEUTICS INC VERA | RA CAPITAL MANAGEMENT L.P. | 2,000,000 7.500% | 2,000,000 (New Position) | Filing History |
| 2022-02-18 4:36 pm Sale | 2021-12-31 | 13G | SCPHARMACEUTICALS INC SCPH | RA CAPITAL MANAGEMENT L.P. | 2,691,770 9.840% | -4,000,000 (-59.77%) | Filing History |
| 2022-02-14 4:11 pm Unchanged | 2021-12-31 | 13G | PHASEBIO PHARMACEUTICALS INC C PHASQ | RA CAPITAL MANAGEMENT L.P. | 2,850,000 5.900% | 0 (Unchanged) | Filing History |